Loading...
•
Jun 30, 2021
Bicycle Q2 2021 Earnings Report
Reported financial results for the second quarter ended June 30, 2021 and provided recent corporate updates.
Key Takeaways
Bicycle Therapeutics reported their Q2 2021 financial results, highlighting significant progress in company-sponsored clinical programs.
Made significant progress executing on company-sponsored clinical programs.
Intend to announce interim clinical data from Phase I portion of Phase I/II clinical trials of BT5528 and BT8009.
Expected Phase I/II BT7840 trial initiation in the second half of the year.
License and collaboration agreement with Ionis provides further validation for Bicycle's technology.
Forward Guidance
Bicycle Therapeutics looks forward to announcing multiple upcoming key clinical milestones in the second half of the year.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...